Literature DB >> 10528696

Haemolytic uraemic syndrome after gemcitabine treatment for pancreatic carcinoma.

M Choi, A Woywodt, U Göbel, W Schneider, R Kettritz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10528696     DOI： 10.1093/ndt/14.10.2523

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

1.  Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma.

Authors:  Adarsh Das; Andrew Dean; Tim Clay
Journal:  BMJ Case Rep       Date:  2019-04-08

2.  Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.

Authors:  Florence Daviet; Franck Rouby; Pascale Poullin; Julie Moussi-Francès; Marion Sallée; Stéphane Burtey; Julien Mancini; Florence Duffaud; Renaud Sabatier; Bertrand Pourroy; Aurélie Grandvuillemin; Steven Grange; Véronique Frémeaux-Bacchi; Paul Coppo; Joëlle Micallef; Noémie Jourde-Chiche
Journal:  Br J Clin Pharmacol       Date:  2018-12-18       Impact factor: 4.335

3.  tHe USual Suspects.

Authors:  Peter Maginnis; John Anderton; Beena Nair; Alexander Woywodt
Journal:  NDT Plus       Date:  2011-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.